Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Type here to filter the list

Tuesday, Jul 15th
8:00 AM - 12:00 PM ET
Ensuring Patient Safety through Analytical Control of Impurities Across Modalities
Location: Vienna Ballroom: North
Moderator: Eric Munson, Ph.D.
Pharmaceutical Analysis Track
Tuesday, Jul 15th
8:05 AM - 8:35 AM ET
Extractables and Leachables: Analytical Strategies for Patient Safety
Location: Vienna Ballroom: North
Speaker: Subathra Ramamoorthy, MS, RPh – Veranova
Pharmaceutical Analysis Track
Tuesday, Jul 15th
8:35 AM - 9:05 AM ET
Characterization of Oxidation as a Non-Critical Quality Attribute
Location: Vienna Ballroom: North
Speaker: Benjamin K. Wheat, MS (he/him/his) – Pfizer
Pharmaceutical Analysis Track
Tuesday, Jul 15th
9:05 AM - 9:35 AM ET
Identifying and Quantifying Elemental Impurities Using X-Ray Fluorescence
Location: Vienna Ballroom: North
Speaker: Dylan Lundgren, MS – Malvern Panalytical
Pharmaceutical Analysis Track
Tuesday, Jul 15th
10:05 AM - 10:35 AM ET
Deconvolution and Identification of a Packaging Component Leachable from Blister Packed Tablets on Stability – A Case Study
Location: Vienna Ballroom: North
Speaker: Adam Socia, PhD – Organon
Pharmaceutical Analysis Track
Tuesday, Jul 15th
10:35 AM - 11:05 AM ET
A Unified Approach to Mass Balance in Pharmaceutical Stress Testing
Location: Vienna Ballroom: North
Speaker: Stacey Marden, PhD (she/her/hers) – AstraZeneca Pharmaceuticals
Pharmaceutical Analysis Track
Tuesday, Jul 15th
11:05 AM - 11:55 AM ET
Ensuring Patient Safety through Analytical Control of Impurities Across Modalities: Panel Discussion
Location: Vienna Ballroom: North
Moderator: Eric Munson, Ph.D.
Speaker: Subathra Ramamoorthy, MS, RPh – Veranova
Speaker: Benjamin K. Wheat, MS (he/him/his) – Pfizer
Speaker: Dylan Lundgren, MS – Malvern Panalytical
Speaker: Adam Socia, PhD – Organon
Speaker: Stacey Marden, PhD (she/her/hers) – AstraZeneca Pharmaceuticals
Pharmaceutical Analysis Track
Tuesday, Jul 15th
11:55 AM - 12:00 PM ET
Closing Remarks
Location: Vienna Ballroom: North
Pharmaceutical Analysis Track
Tuesday, Jul 15th
12:00 PM - 12:30 PM ET
Automated Viscosity Testing for Drug Formulation, Injectability and Cluster Size Analysis
Location: Vienna Ballroom: North
Partner Presenter: Soheila Shabaniverki
Pharmaceutical Analysis Track
Sponsored By
Tuesday, Jul 15th
1:30 PM - 3:00 PM ET
Transferring Analytical Methods - Challenges and Opportunities
Location: Vienna Ballroom: North
Moderator: Xiuli Li, PhD (she/her/hers) – Eli Lilly and Company
Pharmaceutical Analysis Track
Tuesday, Jul 15th
1:35 PM - 2:00 PM ET
Streamlining Global Analytical Transfers While Maximizing Method Knowledge and Monitoring
Location: Vienna Ballroom: North
Speaker: Amy R. Barker, PhD – Eli Lilly & Company
Pharmaceutical Analysis Track
Tuesday, Jul 15th
2:00 PM - 2:25 PM ET
Risk Assessment to Facilitate and Structure Method Knowledge Transfer to a Receiving Lab
Location: Vienna Ballroom: North
Speaker: Joselito Gonzalez, MS Quality Engineering (he/him/his) – Organon
Pharmaceutical Analysis Track
Tuesday, Jul 15th
2:25 PM - 2:50 PM ET
Ensuring Consistency in Bioassay Method Transfer: Strategies for Overcoming Variability
Location: Vienna Ballroom: North
Speaker: Andrew R. Taylor, MS (he/him/his) – BioAgilytix
Pharmaceutical Analysis Track
Tuesday, Jul 15th
2:50 PM - 3:00 PM ET
Closing Remarks
Location: Vienna Ballroom: North
Moderator: Xiuli Li, PhD (she/her/hers) – Eli Lilly and Company
Pharmaceutical Analysis Track
Tuesday, Jul 15th
3:00 PM - 3:30 PM ET
PBMC Sample Quality for Immune Monitoring
Location: Vienna Ballroom: North
Partner Presenter: Virginia Litwin, PhD (she/her/hers) – Eurofins Clinical Trial Solutions
Pharmaceutical Analysis Track
Sponsored By
Wednesday, Jul 16th
8:00 AM - 12:00 PM ET
Recent Developments in Techniques for Pharmaceutical Analysis
Location: Vienna Ballroom: North
Moderator: Beata Sweryda-Krawiec, PhD – Boehringer Ingelheim
Pharmaceutical Analysis Track
Wednesday, Jul 16th
8:05 AM - 9:00 AM ET
Enzyme-Powered API Manufacturing: Analytical Strategies for Ensuring Drug Quality
Location: Vienna Ballroom: North
Speaker: Funing Yan, PhD – Boehringer Ingelheim Pharma
Pharmaceutical Analysis Track
Wednesday, Jul 16th
9:00 AM - 9:30 AM ET
Detecting and Controlling Residual Enzymes in the Production of Islatravir
Location: Vienna Ballroom: North
Speaker: Gregory Hughes, PhD – Merck & Co.
Pharmaceutical Analysis Track
Wednesday, Jul 16th
10:05 AM - 10:35 AM ET
Broad-Shear, low-volume viscometry for the whole drug lifecycle with nanovisQ™
Location: Vienna Ballroom: North
Speaker: Daniel French, PhD – Qatch Technologies
Pharmaceutical Analysis Track
Wednesday, Jul 16th
10:35 AM - 10:50 AM ET
Automated High-Throughput Solutions for Residual DNA Quantitation: Implementation and Outcomes.
Location: Vienna Ballroom: North
Rapid Fire Presenter: Shruti B. Patel, MS – Merck & Co., Inc.
Pharmaceutical Analysis Track
Wednesday, Jul 16th
10:50 AM - 11:55 AM ET
Recent Developments in Techniques for Pharmaceutical Analysis: Panel Discussion
Location: Vienna Ballroom: North
Speaker: Daniel French, PhD – Qatch Technologies
Rapid Fire Presenter: Shruti B. Patel, MS – Merck & Co., Inc.
Speaker: Funing Yan, PhD – Boehringer Ingelheim Pharma
Speaker: Gregory Hughes, PhD – Merck & Co.
Moderator: Beata Sweryda-Krawiec, PhD – Boehringer Ingelheim
Pharmaceutical Analysis Track
Wednesday, Jul 16th
11:55 AM - 12:00 PM ET
Closing Remarks
Location: Vienna Ballroom: North
Moderator: Beata Sweryda-Krawiec, PhD – Boehringer Ingelheim
Pharmaceutical Analysis Track
Wednesday, Jul 16th
12:00 PM - 12:30 PM ET
Derivatization Procedures in Analysis of Drug Substances
Location: Vienna Ballroom: North
Partner Presenter: Rafail Usatinsky, PhD – Siegfried Grafton Inc., d/b/a “Siegfried Acceleration Hub”
Pharmaceutical Analysis Track
Sponsored By
Wednesday, Jul 16th
1:30 PM - 3:00 PM ET
Accelerating Analytical Development: Strategies and Case Studies
Location: Vienna Ballroom: North
Moderator: Landon Greene, PhD (he/him/his) – Vertex Pharmaceuticals
Pharmaceutical Analysis Track
Wednesday, Jul 16th
1:35 PM - 2:00 PM ET
LCMS-based analytical methods for detecting genotoxic nitrosamine impurities.
Location: Vienna Ballroom: North
Speaker: PhanikumarReddy Satti, Pursuing a PhD in Analytical Chemistry (he/him/his) – confidential
Pharmaceutical Analysis Track
Wednesday, Jul 16th
2:00 PM - 2:25 PM ET
Adopting ICH Q14: A Modern Approach to Analytical Procedure Development
Location: Vienna Ballroom: North
Speaker: Jamie T. Wasylenko, MS (she/her/hers) – AbbVie
Pharmaceutical Analysis Track
Wednesday, Jul 16th
2:25 PM - 2:50 PM ET
Amorphous Solid Dispersions: Water Increase Challenges and Mitigation Best Practices
Location: Vienna Ballroom: North
Speaker: Erin Copeland Jones – Eli Lilly and Company
Pharmaceutical Analysis Track
Wednesday, Jul 16th
2:50 PM - 3:00 PM ET
Closing Remarks
Location: Vienna Ballroom: North
Moderator: Landon Greene, PhD (he/him/his) – Vertex Pharmaceuticals
Pharmaceutical Analysis Track
Wednesday, Jul 16th
4:00 PM - 4:45 PM ET
Accelerating Analytical Development: Strategies and Case Studies: Rapid Fires
Location: Vienna Ballroom: North
Rapid Fire Moderator: Gregory Sacha, PhD (he/him/his) – Simtra BioPharma Solutions
Pharmaceutical Analysis Track
Wednesday, Jul 16th
4:00 PM - 4:15 PM ET
Utilization of Chelators for Analyzing Oxidative Degradation of Antibody Therapeutics
Location: Vienna Ballroom: North
Rapid Fire Presenter: Poulami Majumder, PhD (she/her/hers) – Eli Lilly and Company
Pharmaceutical Analysis Track
Wednesday, Jul 16th
4:15 PM - 4:30 PM ET
Addressing Challenges of Validating Quantitative Impurity Methods for Controlling Biologics
Location: Vienna Ballroom: North
Rapid Fire Presenter: Joseph J. Tulock, II, PhD – Labcorp
Pharmaceutical Analysis Track
Wednesday, Jul 16th
4:30 PM - 4:45 PM ET
Comparing Peroxide Quantitation Assays: A Study on Peptide Drug Degradation
Location: Vienna Ballroom: North
Rapid Fire Presenter: Kingshuk Dutta, PhD (he/him/his) – Eli Lilly and Company
Pharmaceutical Analysis Track
Thursday, Jul 17th
8:00 AM - 10:35 AM ET
Joint Session on the Relationship Between Impurities and Immunogenicity
Location: Vienna Ballroom: South, East + West
Moderator: Lynn Kamen, PhD – BioAgilytix
Pharmaceutical Analysis TrackBioanalytical Track
Thursday, Jul 17th
8:05 AM - 8:35 AM ET
Framework towards control of immunogenicity risks for impurities and contaminants
Location: Vienna Ballroom: South, East + West
Speaker: Timothy P. Hickling, PhD – Roche
Pharmaceutical Analysis TrackBioanalytical Track
Thursday, Jul 17th
8:35 AM - 9:05 AM ET
Tiered, Data-driven Approach for Assessing the Safety of Peptide-Related Impurities
Location: Vienna Ballroom: South, East + West
Speaker: Robert Siegel, PhD (he/him/his) – Eli Lilly and Company
Pharmaceutical Analysis TrackBioanalytical Track
Thursday, Jul 17th
9:05 AM - 9:35 AM ET
Case Studies Assessing Immunogenicity Risk of Recombinant Therapeutic Protein Attributes with Implications for Parenteral Drug Product Manufacturing
Location: Vienna Ballroom: South, East + West
Speaker: Joseph R. Cohen, PhD (he/him/his) – Amgen Inc.
Pharmaceutical Analysis TrackBioanalytical Track
Thursday, Jul 17th
9:35 AM - 10:30 AM ET
Joint Session on the Relationship Between Impurities and Immunogenicity: Panel Discussion
Location: Vienna Ballroom: South, East + West
Moderator: Lynn Kamen, PhD – BioAgilytix
Speaker: Timothy P. Hickling, PhD – Roche
Speaker: Robert Siegel, PhD (he/him/his) – Eli Lilly and Company
Speaker: Joseph R. Cohen, PhD (he/him/his) – Amgen Inc.
Pharmaceutical Analysis TrackBioanalytical Track
Thursday, Jul 17th
10:30 AM - 10:35 AM ET
Closing Remarks: 2026 SSF Program Chair
Location: Vienna Ballroom: South, East + West
Moderator: Landon Greene, PhD (he/him/his) – Vertex Pharmaceuticals
Pharmaceutical Analysis TrackBioanalytical Track